192 related articles for article (PubMed ID: 38468344)
21. Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis.
Zhang Y; Yang W; Li D; Yang JY; Guan R; Yang MQ
BMC Med Genomics; 2018 Nov; 11(Suppl 5):104. PubMed ID: 30454048
[TBL] [Abstract][Full Text] [Related]
22. A joint analysis of metabolomics and genetics of breast cancer.
Tang X; Lin CC; Spasojevic I; Iversen ES; Chi JT; Marks JR
Breast Cancer Res; 2014 Aug; 16(4):415. PubMed ID: 25091696
[TBL] [Abstract][Full Text] [Related]
23. Pan-cancer evaluation of gene expression and somatic alteration data for cancer prognosis prediction.
Zheng X; Amos CI; Frost HR
BMC Cancer; 2021 Sep; 21(1):1053. PubMed ID: 34563154
[TBL] [Abstract][Full Text] [Related]
24. Integration of multi-omics data to mine cancer-related gene modules.
Li P; Guo M; Sun B
J Bioinform Comput Biol; 2019 Dec; 17(6):1950038. PubMed ID: 32019413
[TBL] [Abstract][Full Text] [Related]
25. [A novel method for efficient screening and annotation of important pathway-associated metabolites based on the modified metabolome and probe molecules].
Li Z; Zheng F; Xia Y; Zhang X; Wang X; Zhao C; Zhao X; Lu X; Xu G
Se Pu; 2022 Sep; 40(9):788-796. PubMed ID: 36156625
[TBL] [Abstract][Full Text] [Related]
26. A workflow for annotating the knowledge gaps in metabolic reconstructions using known and hypothetical reactions.
Vayena E; Chiappino-Pepe A; MohammadiPeyhani H; Francioli Y; Hadadi N; Ataman M; Hafner J; Pavlou S; Hatzimanikatis V
Proc Natl Acad Sci U S A; 2022 Nov; 119(46):e2211197119. PubMed ID: 36343249
[TBL] [Abstract][Full Text] [Related]
27. Pathway-based integration of multi-omics data reveals lipidomics alterations validated in an Alzheimer's disease mouse model and risk loci carriers.
Garcia-Segura ME; Durainayagam BR; Liggi S; Graça G; Jimenez B; Dehghan A; Tzoulaki I; Karaman I; Elliott P; Griffin JL
J Neurochem; 2023 Jan; 164(1):57-76. PubMed ID: 36326588
[TBL] [Abstract][Full Text] [Related]
28. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
29. A kinetic model of Escherichia coli core metabolism satisfying multiple sets of mutant flux data.
Khodayari A; Zomorrodi AR; Liao JC; Maranas CD
Metab Eng; 2014 Sep; 25():50-62. PubMed ID: 24928774
[TBL] [Abstract][Full Text] [Related]
30. Integrated epigenome, whole genome sequence and metabolome analyses identify novel multi-omics pathways in type 2 diabetes: a Middle Eastern study.
Yousri NA; Albagha OME; Hunt SC
BMC Med; 2023 Sep; 21(1):347. PubMed ID: 37679740
[TBL] [Abstract][Full Text] [Related]
31. Metabolome searcher: a high throughput tool for metabolite identification and metabolic pathway mapping directly from mass spectrometry and using genome restriction.
Dhanasekaran AR; Pearson JL; Ganesan B; Weimer BC
BMC Bioinformatics; 2015 Feb; 16(1):62. PubMed ID: 25887958
[TBL] [Abstract][Full Text] [Related]
32. A metabolite-centric view on flux distributions in genome-scale metabolic models.
Riemer SA; Rex R; Schomburg D
BMC Syst Biol; 2013 Apr; 7():33. PubMed ID: 23587327
[TBL] [Abstract][Full Text] [Related]
33. Metabolic Model-Based Integration of Microbiome Taxonomic and Metabolomic Profiles Elucidates Mechanistic Links between Ecological and Metabolic Variation.
Noecker C; Eng A; Srinivasan S; Theriot CM; Young VB; Jansson JK; Fredricks DN; Borenstein E
mSystems; 2016; 1(1):. PubMed ID: 27239563
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive overview of oncogenic pathways in human cancer.
Li F; Wu T; Xu Y; Dong Q; Xiao J; Xu Y; Li Q; Zhang C; Gao J; Liu L; Hu X; Huang J; Li X; Zhang Y
Brief Bioinform; 2020 May; 21(3):957-969. PubMed ID: 31155677
[TBL] [Abstract][Full Text] [Related]
35. Data-adaptive and pathway-based tests for association studies between somatic mutations and germline variations in human cancers.
Chen Z; Liang H; Wei P
Genet Epidemiol; 2023 Dec; 47(8):617-636. PubMed ID: 37822029
[TBL] [Abstract][Full Text] [Related]
36. Integrating untargeted metabolomics, genetically informed causal inference, and pathway enrichment to define the obesity metabolome.
Hsu YH; Astley CM; Cole JB; Vedantam S; Mercader JM; Metspalu A; Fischer K; Fortney K; Morgen EK; Gonzalez C; Gonzalez ME; Esko T; Hirschhorn JN
Int J Obes (Lond); 2020 Jul; 44(7):1596-1606. PubMed ID: 32467615
[TBL] [Abstract][Full Text] [Related]
37. Novel genetic associations with serum level metabolites identified by phenotype set enrichment analyses.
Ried JS; Shin SY; Krumsiek J; Illig T; Theis FJ; Spector TD; Adamski J; Wichmann HE; Strauch K; Soranzo N; Suhre K; Gieger C
Hum Mol Genet; 2014 Nov; 23(21):5847-57. PubMed ID: 24927737
[TBL] [Abstract][Full Text] [Related]
38. A reconciliation of genome-scale metabolic network model of Zymomonas mobilis ZM4.
Nouri H; Fouladiha H; Moghimi H; Marashi SA
Sci Rep; 2020 May; 10(1):7782. PubMed ID: 32385302
[TBL] [Abstract][Full Text] [Related]
39. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
40. An atlas of genome-wide gene expression and metabolite associations and possible mediation effects towards body mass index.
Beuchel C; Dittrich J; Becker S; Kirsten H; Tönjes A; Kovacs P; Stumvoll M; Loeffler M; Teren A; Thiery J; Isermann B; Ceglarek U; Scholz M
J Mol Med (Berl); 2023 Oct; 101(10):1305-1321. PubMed ID: 37672078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
